Differential gene expression in leiomyosarcoma

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

BACKGROUND. Leiomyosarcomas (LMS) are a common subtype of soft tissue sarcoma. The molecular causes of the disease remain unclear. METHODS. In the current study, gene expression in LMS, leiomyomas, and normal myometrium was examined. RNA was prepared and gene expression was determined using microarray analysis arrays containing approximately 12,000 known genes and 48,000 expressed squence tags (ESTs). RESULTS. A number of genes were found to be differentially expressed in these sample sets, and six genes including cyclin-dependent kinase inhibitor 2A, diaphanous (Drosophila homolog) 3, doublecortin, calpain 6, interleukin-17B, and proteolipid 1 were found to be overexpressed in LMS compared with normal myometrium and 18 other tissues. Sets of genes were identified whose expression could be used to cluster samples with either LMS, leiomyomas, or normal myometrium. CONCLUSIONS. The authors concluded that differences in gene expression can be detected between LMS and leiomyomas, normal myometrium, and other tissues, and that these changes in gene expression may yield clues with regard to the pathophysiology of leiomyosarcoma.

Original languageEnglish (US)
Pages (from-to)1029-1038
Number of pages10
JournalCancer
Volume98
Issue number5
DOIs
StatePublished - Sep 1 2003

Fingerprint

Leiomyosarcoma
Myometrium
Gene Expression
Leiomyoma
Genes
Cyclin-Dependent Kinase Inhibitor p16
Proteolipids
Calpain
Interleukin-17
Microarray Analysis
Sarcoma
Drosophila
RNA

Keywords

  • Calpain 6
  • Cancer
  • Cyclin-dependent kinase inhibitor 2A
  • Diaphanous
  • Doublecortin
  • Gene expression
  • Interleukin-17B
  • Leiomyosarcoma (LMS)
  • Microarray
  • Myometrium
  • Osteopontin
  • Pituitary tumor transforming
  • Proteolipid 1
  • Ubiquitin
  • Uterus

Cite this

Differential gene expression in leiomyosarcoma. / Skubitz, Keith M; Skubitz, Amy P.

In: Cancer, Vol. 98, No. 5, 01.09.2003, p. 1029-1038.

Research output: Contribution to journalArticle

@article{02acd083de354332894569006df687d1,
title = "Differential gene expression in leiomyosarcoma",
abstract = "BACKGROUND. Leiomyosarcomas (LMS) are a common subtype of soft tissue sarcoma. The molecular causes of the disease remain unclear. METHODS. In the current study, gene expression in LMS, leiomyomas, and normal myometrium was examined. RNA was prepared and gene expression was determined using microarray analysis arrays containing approximately 12,000 known genes and 48,000 expressed squence tags (ESTs). RESULTS. A number of genes were found to be differentially expressed in these sample sets, and six genes including cyclin-dependent kinase inhibitor 2A, diaphanous (Drosophila homolog) 3, doublecortin, calpain 6, interleukin-17B, and proteolipid 1 were found to be overexpressed in LMS compared with normal myometrium and 18 other tissues. Sets of genes were identified whose expression could be used to cluster samples with either LMS, leiomyomas, or normal myometrium. CONCLUSIONS. The authors concluded that differences in gene expression can be detected between LMS and leiomyomas, normal myometrium, and other tissues, and that these changes in gene expression may yield clues with regard to the pathophysiology of leiomyosarcoma.",
keywords = "Calpain 6, Cancer, Cyclin-dependent kinase inhibitor 2A, Diaphanous, Doublecortin, Gene expression, Interleukin-17B, Leiomyosarcoma (LMS), Microarray, Myometrium, Osteopontin, Pituitary tumor transforming, Proteolipid 1, Ubiquitin, Uterus",
author = "Skubitz, {Keith M} and Skubitz, {Amy P}",
year = "2003",
month = "9",
day = "1",
doi = "10.1002/cncr.11586",
language = "English (US)",
volume = "98",
pages = "1029--1038",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Differential gene expression in leiomyosarcoma

AU - Skubitz, Keith M

AU - Skubitz, Amy P

PY - 2003/9/1

Y1 - 2003/9/1

N2 - BACKGROUND. Leiomyosarcomas (LMS) are a common subtype of soft tissue sarcoma. The molecular causes of the disease remain unclear. METHODS. In the current study, gene expression in LMS, leiomyomas, and normal myometrium was examined. RNA was prepared and gene expression was determined using microarray analysis arrays containing approximately 12,000 known genes and 48,000 expressed squence tags (ESTs). RESULTS. A number of genes were found to be differentially expressed in these sample sets, and six genes including cyclin-dependent kinase inhibitor 2A, diaphanous (Drosophila homolog) 3, doublecortin, calpain 6, interleukin-17B, and proteolipid 1 were found to be overexpressed in LMS compared with normal myometrium and 18 other tissues. Sets of genes were identified whose expression could be used to cluster samples with either LMS, leiomyomas, or normal myometrium. CONCLUSIONS. The authors concluded that differences in gene expression can be detected between LMS and leiomyomas, normal myometrium, and other tissues, and that these changes in gene expression may yield clues with regard to the pathophysiology of leiomyosarcoma.

AB - BACKGROUND. Leiomyosarcomas (LMS) are a common subtype of soft tissue sarcoma. The molecular causes of the disease remain unclear. METHODS. In the current study, gene expression in LMS, leiomyomas, and normal myometrium was examined. RNA was prepared and gene expression was determined using microarray analysis arrays containing approximately 12,000 known genes and 48,000 expressed squence tags (ESTs). RESULTS. A number of genes were found to be differentially expressed in these sample sets, and six genes including cyclin-dependent kinase inhibitor 2A, diaphanous (Drosophila homolog) 3, doublecortin, calpain 6, interleukin-17B, and proteolipid 1 were found to be overexpressed in LMS compared with normal myometrium and 18 other tissues. Sets of genes were identified whose expression could be used to cluster samples with either LMS, leiomyomas, or normal myometrium. CONCLUSIONS. The authors concluded that differences in gene expression can be detected between LMS and leiomyomas, normal myometrium, and other tissues, and that these changes in gene expression may yield clues with regard to the pathophysiology of leiomyosarcoma.

KW - Calpain 6

KW - Cancer

KW - Cyclin-dependent kinase inhibitor 2A

KW - Diaphanous

KW - Doublecortin

KW - Gene expression

KW - Interleukin-17B

KW - Leiomyosarcoma (LMS)

KW - Microarray

KW - Myometrium

KW - Osteopontin

KW - Pituitary tumor transforming

KW - Proteolipid 1

KW - Ubiquitin

KW - Uterus

UR - http://www.scopus.com/inward/record.url?scp=0041386235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041386235&partnerID=8YFLogxK

U2 - 10.1002/cncr.11586

DO - 10.1002/cncr.11586

M3 - Article

VL - 98

SP - 1029

EP - 1038

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 5

ER -